1. Summary Information
|
|
|
Country |
|
|
Company Name |
OTIRA
PHARMACEUTICALS PRIVATE LIMITED |
Principal Name 1 |
Mr. Bhim Sain Bajaj |
|
Status |
Recently
Recommenced Business |
Principal Name 2 |
Mr. Anu Sheel Bajaj |
|
|
|
Registration # |
|
|
Street Address |
Flat No. 202,
Jamuna Tirth Apartments, Dharam Karan Road, Ameerpet, Hyderabad – 500016,
Andhra Pradesh, India |
||
|
Established Date |
25.08.1987 |
SIC Code |
-- |
|
Telephone# |
91-40-23415667 |
Business Style 1 |
Manufacturer of Pharmaceuticals Products. |
|
Fax # |
-- |
Business Style 2 |
-- |
|
Homepage |
-- |
Product Name 1 |
-- |
|
# of employees |
-- |
Product Name 2 |
-- |
|
Paid up capital |
1,005,000 |
Product Name 3 |
-- |
|
Shareholders |
Anu Sheel Bajaj - 4200 |
Banking |
State
Bank of India |
|
Public Limited Corp. |
-- |
Business Period |
24 years |
|
IPO |
--- |
International Ins. |
- |
|
Public |
--- |
Rating |
Ca (18) |
|
Related
Company |
|||
|
Relation
-- |
Country
-- |
Company
Name |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
250,000 |
Current Liabilities |
157,000 |
|
Inventories |
-- |
Long-term Liabilities |
1,901,000 |
|
Fixed Assets |
11,358,000 |
Other Liabilities |
258,000 |
|
Deferred Assets |
-- |
Total Liabilities |
2,316,000 |
|
Invest& other Assets |
67,000 |
Retained Earnings |
17,920,000 |
|
|
|
Net Worth |
9,359,000 |
|
Total Assets |
11,675,000 |
Total Liab. & Equity |
11,675,000 |
|
Total Assets (Previous Year) |
2,658,000 |
|
|
|
P/L Statement as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Sales |
-- |
Net Profit |
(507,000) |
|
Sales(Previous yr) |
-- |
Net Profit(Prev.yr) |
(303,000) |
MIRA
INFORM REPORT
|
Report Date : |
13.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
OTIRA PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Flat No. 202, Jamuna Tirth Apartments, Dharam Karan Road, Ameerpet,
Hyderabad – 500016, Andhra Pradesh |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
25.08.1987 |
|
|
|
|
Com. Reg. No.: |
007723 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.2.500 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239AP1987PTC007723 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
HYDO00212C |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals Products. |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca (18) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Recently Recommenced Business |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
As confirmed by Mr. Kiran Kumar, Accountant, the company has
recommenced its commercial business activities in June, 2011. He further
stated that the activities of the company were closed from the year
2000-2010. Also the management of the company has changed recently. Vamsi
Krishna and Swarnakumari are the present directors of the company. Initially, the company can be considered for business dealings on a
secured trade terms conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Mr. Kiran Kumar |
|
Designation : |
Accountant |
|
Date : |
07.09.2011 |
LOCATIONS
|
Registered Office : |
Flat No. 202, Jamuna Tirth Apartments, Dharam Karan Road, Ameerpet,
Hyderabad – 500016, Andhra Pradesh, India |
|
Tel. No.: |
91-40-23415667 |
|
E-Mail : |
|
|
|
|
|
Factory : |
Survey No.637, Temple Road, Bonthapally Village, Jinnaram Mandal,
Medak District, Andhra Pradesh, India |
DIRECTORS
AS ON 12.08.2010
|
Name : |
Mr. Bhim Sain Bajaj |
|
Designation : |
Director |
|
Address : |
B-302, Hill View Apartments, 6-3-886, Raj Bhawan Road, Somajiguda
Circle, Hyderabad – 500082, Andhra Pradesh, India |
|
Date of Birth/Age : |
19.09.1927 |
|
Date of Appointment : |
25.08.1987 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24239AP1987PTC007723 |
OTIRA PHARMACEUTICALS PVT
LTD |
Director |
25/08/1987 |
25/08/1987 |
04/10/2010 |
Active |
NO |
|
2 |
L24230AP1981PLC003201 |
NATCO PHARMA LIMITED |
Director |
30/03/2002 |
30/03/2002 |
- |
Active |
NO |
|
3 |
U85110AP2003PTC040317 |
PACIFIC HOSPITALS PRIVATE
LIMITED |
Director |
12/03/2003 |
12/03/2003 |
- |
Active |
NO |
|
4 |
U85100AP2009PTC066172 |
Tran-Scell Biologics
Private Limited |
Director |
09/12/2009 |
09/12/2009 |
- |
Active |
NO |
|
Name : |
Mr. Anu Sheel Bajaj |
|
Designation : |
Managing Director |
|
Address : |
B-302, Hill View Apartments, 6-3-886, Raj Bhawan Road, Somajiguda
Circle, Hyderabad – 500082, Andhra Pradesh, India |
|
Date of Birth/Age : |
23.11.1960 |
|
Date of Appointment : |
25.08.1987 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24239AP1987PTC007723 |
OTIRA PHARMACEUTICALS PVT
LTD |
Managing director |
25/08/1987 |
25/08/1987 |
04/10/2010 |
Active |
NO |
|
Name : |
Mrs. Vinita Bajaj |
|
Designation : |
Director |
|
Address : |
B-302, Hill View Apartments, 6-3-886, Raj Bhawan Road, Somajiguda
Circle, Hyderabad – 500082, Andhra Pradesh, India |
|
Date of Birth/Age : |
23.09.1966 |
|
Date of Appointment : |
01.01.1992 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24239AP1987PTC007723 |
OTIRA PHARMACEUTICALS PVT
LTD |
Director |
01/01/1992 |
01/01/1992 |
04/12/2010 |
Active |
NO |
|
Name : |
Mr. Vasmi Krishna |
|
Designation : |
Managing Director |
|
|
|
|
Name : |
Mr. Swarnakumari |
|
Designation : |
Director |
KEY EXECUTIVES
|
Name : |
Mr. Mr. Kiran Kumar |
|
Designation : |
Accountant |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 12.08.2010
|
Names of Shareholders |
|
No. of Shares |
|
Anu Sheel Bajaj |
|
4200 |
|
Bhim Sain Bajaj |
|
345 |
|
B.S.Bajaj (HUF) |
|
3855 |
|
Mrs.Prem Lata Bajaj |
|
1380 |
|
Mrs. Vinita Bajaj |
|
270 |
|
Total |
|
10050 |
AS ON 12.08.2010
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Products. |
GENERAL INFORMATION
|
No. of Employees : |
Not Divulged |
|||||||||
|
|
|
|||||||||
|
Bankers : |
State Bank of India, Balkampet Branch, Balkampet, Hyderabad - 500038, Andhra Pradesh, India |
|||||||||
|
|
|
|||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
U. Srinivasa Murthy Chartered Accountant |
|
Address : |
303 Surabhi Lotus Apartments, Nagarjuna Nagar Colony Ameerpet,
Hyderabad – 500073, Andhra Pradesh, India |
|
Tel No.: |
91-40-23746488/23754538 |
|
|
|
|
Associates/Subsidiaries : |
NA |
CAPITAL STRUCTURE
AS ON 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
25000 |
Equity Shares |
Rs.100/- each |
Rs.2.500 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10050 |
Equity Shares |
Rs.100/-
each |
Rs.1.005
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
1.005 |
1.005 |
1.005 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
17.920 |
7.492 |
7.492 |
|
|
4] (Accumulated Losses) |
(9.566) |
(9.058) |
(8.754) |
|
|
NETWORTH |
9.359 |
(0.561) |
(0.257) |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
1.901 |
1.821 |
1.821 |
|
|
TOTAL BORROWING |
1.901 |
1.821 |
1.821 |
|
|
DEFERRED TAX LIABILITIES |
0.258 |
0.294 |
0.355 |
|
|
|
|
|
|
|
|
TOTAL |
11.518 |
1.554 |
1.919 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
11.358 |
1.541 |
1.864 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.067 |
0.067 |
0.067 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
0.000
|
0.244 |
0.244 |
|
|
Sundry Debtors |
0.000
|
0.057 |
0.058 |
|
|
Cash & Bank Balances |
0.026
|
0.286 |
0.307 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
0.224
|
0.463 |
0.468 |
|
Total
Current Assets |
0.250
|
1.050 |
1.077 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
0.125
|
0.773 |
0.764 |
|
|
Other Current Liabilities |
0.032
|
0.032 |
0.026 |
|
|
Provisions |
0.000
|
0.299 |
0.299 |
|
Total
Current Liabilities |
0.157
|
1.104 |
1.089 |
|
|
Net Current Assets |
0.093
|
(0.054) |
(0.012) |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
11.518 |
1.554 |
1.919 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
0.000 |
0.000 |
0.000 |
|
|
|
Other Income |
0.882 |
0.236 |
0.183 |
|
|
|
TOTAL (A) |
0.882 |
0.236 |
0.183 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Material Consumed |
0.045 |
0.000 |
0.000 |
|
|
|
Salaries and Wages |
0.119 |
0.141 |
0.152 |
|
|
|
Other Manufacturing, Administrative Expenses |
0.920 |
0.130 |
0.165 |
|
|
|
Increased / (Decreased) In stocks |
0.155 |
0.000 |
0.000 |
|
|
|
TOTAL (B) |
1.239 |
0.271 |
0.317 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
(0.357) |
(0.035) |
(0.134) |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
(0.357) |
(0.035) |
(0.134) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.186 |
0.324 |
0.324 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
(0.543) |
(0.359) |
(0.458) |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
(0.036) |
(0.056) |
(0.044) |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
(0.507) |
(0.303) |
(0.414) |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
(9.058) |
(8.754) |
(8.339) |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
(9.566) |
(9.058) |
(8.754) |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
(57.48)
|
(128.38) |
(226.23) |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
NA |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(4.68)
|
(13.85) |
(15.57) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.06)
|
(0.64) |
(1.78) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.22
|
(5.21) |
(11.32) |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.59
|
0.95 |
0.99 |
LOCAL AGENCY FURTHER INFORMATION
NOTE:
The registered office address of the company
has been shifted from 401, lakshmi Nivas, Greenlands, Ameerpet, Hyderabad –
500016, Andhra Pradesh, India to present w.e.f. 09.03.2011
FORM 8:
|
Corporate identity number of the company |
U24239AP1987PTC007723 |
|
Name of the company |
OTIRA PHARMACEUTICALS PVT LTD |
|
Address of the registered office or of the
principal place of business in |
Flat No 202 Jamuna Tirth Apartments,
Dharam Karan Road Ameerpet, Hyderabad – 500016, Andhra Pradesh, India |
|
This form is for |
Creation of charge Modification of charge |
|
Type of charge |
Book Debts Immovable Property Movable Property Floating Charge |
|
Particular of charge holder |
State Bank of India |
|
Nature of instrument creating charge |
1) Agreement of Hypothecation of Goods and
Assets (Form C.2). 2) Memorandum for Recording creation of
mortgage by deposit of Title deeds. 3) Letter regarding the grant of
individual limits within the overall limit (Form C.5). 4) Agreement of Loan for Overall Limit
(Form C.1). |
|
Date of instrument Creating the charge |
06/06/2011 |
|
Amount secured by the charge |
Rs.86.000 Millions |
|
Brief of the principal terms an conditions
and extent and operation of the charge |
Rate of Interest Cash Credit: At 6.50% above Base Rate,
Base Rate=9.25% p.a. Present
effective rate of interest is 14.75% p.a. with monthly rests. 2) SLC: At 1% above the rate applicable to
Cash Credit. Terms of Repayment Working Capital : on demand. Margin 1) Finished Goods - 25% 2) Letters of Credit / Buyers Credit -20% 3) Book debts / Receivables (Cover period
- 120 days) - 40% Extent and Operation of the charge The charge operates as security, inter
alia, for the due repayment by the company to the State Bank of India,
Balkampet Branch, Hyderabad for its limits sanctioned to the extent of Rs.8.60 Crores, together with
interest, additional interest, liquidated damages, commitment charges, premia
on prepayment or on redemption, costs, charges, expenses and all other moneys
payable by the Company to State Bank of India, Balkampet Branch, Hyderabad. |
|
Short particulars of the property charged |
Hypothecation of Exclusive first charge on
all the current assets of the company namely stocks, stores and spares not
relating to Plant and Machinery (Consumable stores and spares), Bills
Receivables and book debts and all other current assets of the borrower.
Hypothecation of the whole of the movable properties of the company (Fixed
Assets) including its movable Plant and Machinery whether attached to the
earth or otherwise, machinery spares, tools and accessories and others. EM of
Ac.2.21.14 Gts of land and factory building constructed thereon in Sy.
No.637, 659 and 660 situated at Temple Road, Bonthapalli Village, Jinnaram
(M), Medak (Dist), standing in the name of the Co. |
FIXED ASSETS:
·
Land
·
Building
·
Plant and Machinery
·
Electrical installation
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.97 |
|
|
1 |
Rs.74.21 |
|
Euro |
1 |
Rs.63.66 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
2 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
2 |
|
--PROFITABILIRY |
1~10 |
-- |
|
--LIQUIDITY |
1~10 |
2 |
|
--LEVERAGE |
1~10 |
2 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
2 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
18 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.